No Data
No Data
Inventiva S.A. Prepares for May 2025 General Meeting With Proxy Mailings
Inventiva Announces Publication Of Its Analysis On New Biomarker Signatures Predictive Of Histological Response In Patients With MASH Treated With Lanifibranor In Peer-Reviewed Medical Journal Clinical Gastroenterology And Hepatology
20-F: FY2024 Annual Report
Inventiva Announces Filing of Its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F
Inventiva Announces General Meeting to Discuss 2024 Financials and Strategic Initiatives
6-K: Report of foreign private issuer (related to financial reporting)